Director
Boehringer Ingelheim
Fenglei Huang, PhD. FCP, is the Director and Team Lead of Clinical Pharmacology at Boehringer Ingelheim, where he also chairs the Drug-Drug Interaction Expert Group. With a Ph.D. in Pharmaceutical Science from the University of Florida, he is an elected fellow of the American College of Clinical Pharmacology (ACCP). He has made notable contributions to the field, co-authoring over 40 peer-reviewed scientific articles, and presenting at over 60 national and international conferences.